Xtx Topco LTD Atara Biotherapeutics, Inc. Transaction History

Xtx Topco LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.23 - $1.74 $303 - $2,298	1,321 Added 3.86%	35,560 $18,000
Q3 2023 Nov 13, 2023	SELL	$1.41 - $2.31 $144,668 - $237,010	-102,602 Reduced 74.98%	34,239 $50,000
Q2 2023 Aug 14, 2023	BUY	$1.5 - $3.04 $205,261 - $415,996	136,841 New	136,841 $220,000
Q4 2022 Feb 14, 2023	SELL	$2.85 - $5.18 $392,838 - $714,000	-137,838 Reduced 82.79%	28,652 $93,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $474,496 - $1.45 Million	166,490 New	166,490 $629,000

Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $109,192 - $229,094	-23,282 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.44 - $16.89 $196,500 - $393,232	23,282 New	23,282 $216,000
Q2 2021 Aug 12, 2021	SELL	$12.89 - $16.58 $136,427 - $175,482	-10,584 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$14.0 - $20.72 $148,176 - $219,300	10,584 New	10,584 $152,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.